HIV therapy has advanced greatly in the past couple of decades. Along with advances in treatment have come new adverse effects associated with therapy. We present a case of Toxoplasma encephalitis following initiation of HAART consistent with the emerging syndrome known as immune restoration disease.
View Article and Find Full Text PDFCitalopram is a member of the selective serotonin reuptake inhibitor class of antidepressants. In 1998, citalopram was approved by the US Food and Drug Administration for the treatment of major depression. Like the other selective serotonin reuptake inhibitors, citalopram enjoys a relatively benign side effect profile compared with the tricyclic antidepressants and the monoamine oxidase inhibitors.
View Article and Find Full Text PDF